Business Description
Klotho Neurosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US49876K1034
Total Employee Number:
3Description
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.16 | |||||
Equity-to-Asset | 0.99 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -570.2 | |||||
3-Year EPS without NRI Growth Rate | -584 | |||||
3-Year Book Growth Rate | -13.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.22 | |||||
9-Day RSI | 62.8 | |||||
14-Day RSI | 61.91 | |||||
3-1 Month Momentum % | -45.64 | |||||
6-1 Month Momentum % | -62.74 | |||||
12-1 Month Momentum % | -18.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 83.59 | |||||
Quick Ratio | 83.59 | |||||
Cash Ratio | 79.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.4 | |||||
Shareholder Yield % | 1.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -236.57 | |||||
ROA % | -195.82 | |||||
ROIC % | -254.71 | |||||
3-Year ROIIC % | -241.6 | |||||
ROC (Joel Greenblatt) % | -14426.92 | |||||
ROCE % | -155.62 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 3.72 | |||||
Price-to-Tangible-Book | 4.77 | |||||
EV-to-EBIT | -7.71 | |||||
EV-to-EBITDA | -7.71 | |||||
EV-to-FCF | -10.42 | |||||
| Price-to-Net-Current-Asset-Value | 4.77 | |||||
| Price-to-Net-Cash | 5.24 | |||||
Earnings Yield (Greenblatt) % | -12.97 | |||||
FCF Yield % | -9.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KLTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klotho Neurosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.32 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 540.97 | ||
| 14-Day RSI | 61.91 | ||
| 14-Day ATR ($) | 0.092165 | ||
| 20-Day SMA ($) | 0.390245 | ||
| 12-1 Month Momentum % | -18.46 | ||
| 52-Week Range ($) | 0.1135 - 3.9099 | ||
| Shares Outstanding (Mil) | 108.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Klotho Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Klotho Neurosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Klotho Neurosciences Inc Frequently Asked Questions
What is Klotho Neurosciences Inc(KLTO)'s stock price today?
The current price of KLTO is $0.52. The 52 week high of KLTO is $3.91 and 52 week low is $0.11.
When is next earnings date of Klotho Neurosciences Inc(KLTO)?
The next earnings date of Klotho Neurosciences Inc(KLTO) is .
Does Klotho Neurosciences Inc(KLTO) pay dividends? If so, how much?
Klotho Neurosciences Inc(KLTO) does not pay dividend.
Guru Commentaries on NAS:KLTO
No articles.
Press Release
Articles on Klotho Neurosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers